24-hydroxycholesterol has been researched along with Central Nervous System Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackley, MA; Bai, Z; Beckley, JT; Blanco, MJ; Dai, J; Doherty, JJ; Harrison, BL; Hill, MD; Hoffmann, EC; Kazdoba, TM; Lanzetta, D; Lewis, M; Quirk, MC; Robichaud, AJ; Salituro, FG | 1 |
1 other study(ies) available for 24-hydroxycholesterol and Central Nervous System Disease
| Article | Year |
|---|---|
SAGE-718: A First-in-Class
Topics: Allosteric Regulation; Central Nervous System Diseases; Cognitive Dysfunction; Humans; Neurosteroids; Receptors, N-Methyl-D-Aspartate | 2022 |